 To develop CLEAR, we compared DEGs from RNA extracted from FACS-derived CD5+ and CD5- cells from a single chronic lymphocytic leukemia patient diluted to input RNA levels of 10-, 100- and 1,000pg. Data quality at ultralow input levels are known to be noisy.
<clarity>  To develop CLEAR, we compared DEGs from RNA extracted from FACS-derived CD5+ and CD5- cells from a single chronic lymphocytic leukemia patient diluted to input RNA levels of 10-, 100- and 1,000pg. Data quality at ultralow input levels are known to be noisy.
 To develop CLEAR, we compared DEGs from RNA extracted from FACS-derived CD5+ and CD5- cells from a single chronic lymphocytic leukemia patient were used to develop CLEAR.